Rapamune and Osteoporosis - a phase IV clinical study of FDA data
Summary:
Osteoporosis is reported as a side effect among people who take Rapamune (sirolimus), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Prednisone, and have Diabetes.
The phase IV clinical study analyzes which people have Osteoporosis when taking Rapamune. It is created by eHealthMe based on reports of 13,732 people who have side effects when taking Rapamune from the FDA, and is updated regularly.
What is Rapamune?
Rapamune has active ingredients of sirolimus. It is often used in kidney transplant. eHealthMe is studying from 13,848 Rapamune users. Check the latest studies of Rapamune.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 1,814 drugs and 1,900 conditions by eHealthMe. Check the latest studies of Osteoporosis.
13,732 people reported to have side effects when taking Rapamune.
Among them, 43 people (0.31%) have Osteoporosis.

Among these 43 people:
How long have people been on Rapamune when they have Osteoporosis? *
- < 1 month: 0.0 %
- 1 - 6 months: 77.78 %
- 6 - 12 months: 11.11 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 11.11 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Osteoporosis when taking Rapamune? *
- female: 47.62 %
- male: 52.38 %
What is the age of people who have Osteoporosis when taking Rapamune? *
- 0-1: 0.0 %
- 2-9: 2.78 %
- 10-19: 0.0 %
- 20-29: 2.78 %
- 30-39: 2.78 %
- 40-49: 13.89 %
- 50-59: 50.0 %
- 60+: 27.78 %
What are other drugs people take besides Rapamune? *
- Prednisone: 11 people, 25.58%
- Coumadin: 10 people, 23.26%
- Ms Contin: 8 people, 18.60%
- Lasix: 8 people, 18.60%
- Prilosec: 8 people, 18.60%
- Lyrica: 7 people, 16.28%
- Levaquin: 7 people, 16.28%
- Omeprazole: 7 people, 16.28%
- Cellcept: 7 people, 16.28%
- Magnesium Oxide: 6 people, 13.95%
What are other side effects people have besides Osteoporosis? *
- Pneumonia: 13 people, 30.23%
- Diabetes: 13 people, 30.23%
- Weakness: 10 people, 23.26%
- Hyperlipidaemia (presence of excess lipids in the blood): 10 people, 23.26%
- Cellulitis (infection under the skin): 10 people, 23.26%
- Diarrhea: 9 people, 20.93%
- Bone Disorder: 8 people, 18.60%
- Dyspnea (difficult or laboured breathing): 8 people, 18.60%
- Spinal Compression Fracture (fracture due to spinal compression on bone): 8 people, 18.60%
- Sinusitis (inflammation of sinus): 8 people, 18.60%
What are the existing conditions these people have? *
- Immunodeficiency Disorders: 5 people, 11.63%
- Diabetes: 5 people, 11.63%
- Organising Pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue): 3 people, 6.98%
- Pancreatic Disorder: 3 people, 6.98%
- Pain: 2 people, 4.65%
- Indigestion: 2 people, 4.65%
- Type 2 Diabetes: 1 person, 2.33%
- Gastric Ulcer (stomach ulcer): 1 person, 2.33%
- Bone Marrow Disorder: 1 person, 2.33%
- Cardiac Disorder: 1 person, 2.33%
* Approximation only. Some reports may have incomplete information.
Do you take Rapamune and have Osteoporosis?
- Check whether Osteoporosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Rapamune:
- Rapamune (13,848 reports)
Osteoporosis treatments and more:
- Osteoporosis (290,734 reports)
How severe was Osteoporosis and when was it recovered:
Expand to all the drugs that have ingredients of sirolimus:
- Osteoporosis and drugs with ingredients of sirolimus (38 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rapamune:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Osteoporosis:
- Osteoporosis (1,814 drugs)
Browse all the conditions that are associated with Osteoporosis:
- Osteoporosis (1,900 conditions)
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on sirolimus (the active ingredients of Rapamune) and Rapamune (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hyperparathyroidism Secondary and Eating Disorder - 6 seconds ago
- Could Humira cause Transfusion Reaction? - 7 seconds ago
- Could Calcium Gluconate cause Osteonecrosis Of Jaw? - 10 seconds ago
- Could Ambrisentan cause Respiratory Distress? - 11 seconds ago
- Could Cidofovir cause Constipation? - 19 seconds ago
- Drug interactions of Advil and Potassium Chloride - 23 seconds ago
- Could Forteo cause Wound? - 27 seconds ago
- Drug interactions of Carboplatin and Furosemide - 28 seconds ago
- Asthma and Completed Suicide - 32 seconds ago
- Could Symbicort cause Myoclonus? - 33 seconds ago